These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4457268)

  • 1. An antihypertensive action of propranolol in DOCA/salt-treated rats.
    Dusting GJ; Rand MJ
    Clin Exp Pharmacol Physiol; 1974; 1(1):87-98. PubMed ID: 4457268
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol in DOCA hypertensive rats: development of hypertension inhibited and pressor responsiveness enhanced.
    Buñag RD
    Eur J Pharmacol; 1977 Jun; 43(4):323-31. PubMed ID: 880980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of deoxycorticosterone/salt hypertension in the rat on the activity of adrenergic cardiac nerves.
    Bell C; McLachlan EM
    Clin Sci (Lond); 1979 Aug; 57(2):203-10. PubMed ID: 38942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central attenuation of aortic baroreceptor reflex in prehypertensive DOCA-salt-loaded rats.
    Nakamura Y; Takeda K; Nakata T; Hayashi J; Kawasaki S; Lee LC; Sasaki S; Nakagawa M; Ijichi H
    Hypertension; 1988 Sep; 12(3):259-66. PubMed ID: 3169941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific increase in cardiovascular reactivity related to sodium retention in DOCA-salt-treated rats.
    Dusting GJ; Harris GS; Rand MJ
    Clin Sci Mol Med; 1973 Nov; 45(5):571-81. PubMed ID: 4202410
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
    Tsuda K; Masuyama Y
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):68-71. PubMed ID: 2007000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
    Sato Y; Ando K; Fujita T
    Hypertension; 1987 Jan; 9(1):81-7. PubMed ID: 2878880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dominance of adrenergic mechanisms in mediating hypotensive drug-induced renin release in the conscious rat.
    Keeton TK; Pettinger WA
    J Pharmacol Exp Ther; 1979 Feb; 208(2):303-9. PubMed ID: 762664
    [No Abstract]   [Full Text] [Related]  

  • 9. KT3-671, an angiotensin AT1 receptor antagonist, attenuates vascular but not cardiac responses to sympathetic nerve stimulation in pithed rats.
    Takata Y; Kurihara J; Yoda T; Suzuki S; Matsuoka Y; Okubo Y; Kato H
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):427-36. PubMed ID: 11300656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of salt and DOCA on hypothalamic and baroreflex control of blood pressure.
    Takeda K; Nakamura Y; Hayashi J; Kawasaki S; Nakata T; Oguro M; Sasaki S; Nakagawa M
    Clin Exp Hypertens A; 1988; 10 Suppl 1():289-99. PubMed ID: 3242995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotensive action of taurine in DOCA-salt rats--involvement of sympathoadrenal inhibition and endogenous opiate.
    Sato Y; Ogata E; Fujita T
    Jpn Circ J; 1991 May; 55(5):500-8. PubMed ID: 2062001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the pressor and depressor actions of St 155 (2-(2,6--dichlorophenylamino)-2-imidazoline hydrochloride, Catapres).
    Rand MJ; Wilson J
    Eur J Pharmacol; 1968 Apr; 3(1):27-33. PubMed ID: 5658985
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates.
    Fujita T; Sato Y
    J Clin Invest; 1988 Sep; 82(3):993-7. PubMed ID: 2971083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antihypertensive effect of taurine in DOCA-salt rats.
    Fujita T; Sato Y
    J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retardation of the development of hypertension in DOCA-salt rats by renal denervation.
    Takahashi H; Iyoda I; Yamasaki H; Takeda K; Okajima H; Sasaki S; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1984 Jun; 48(6):567-74. PubMed ID: 6547490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented sympathetic nerve activity and pressor responsiveness in DOCA hypertensive rats.
    Takeda K; Buñag RD
    Hypertension; 1980; 2(1):97-101. PubMed ID: 6102966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic involvement in vagal escape and the effects of beta-receptor blocking drugs.
    Raper C; Wale J
    Eur J Pharmacol; 1969 Oct; 8(1):47-57. PubMed ID: 4391045
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased sensitivity to norepinephrine cardiac arrhythmias in the deoxycorticosterone acetate high salt rat before the onset of hypertension.
    Rabkin SW; Fung AY
    Can J Physiol Pharmacol; 1984 Jun; 62(6):605-9. PubMed ID: 6744105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of D- and DL-propranolol on blood pressure and cerebral norepinephrine in rats with DOCA-hypertension.
    Lydtin H; Sommerfeldt H
    Int J Clin Pharmacol; 1972 Nov; 6(4):328-31. PubMed ID: 4641848
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathogenesis of DOCA-salt hypertension.
    Schenk J; McNeill JH
    J Pharmacol Toxicol Methods; 1992 May; 27(3):161-70. PubMed ID: 1498343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.